The current methods were developed as part of studies of Rett syndrome, MECP2 duplication syndrome, CDKL5 deficiency disorder, and FOXG1 syndrome but these same methods can be similarly applied or modified for studies with other NDDs and developmental and epileptic encephalopathies. This evidence concerns the gene MECP2 and Rett syndrome.